For example, haptoglobin and its glycosylated forms have been identified as potential biomarkers for non-small cell lung cancer and hepatocellular carcinoma [16,17], calcitonin for thyroid cancers [18], and gastrin for gastric and colorectal cancers [19]. This evidence concerns the gene GAST and non-small cell lung carcinoma.